title: Recurrence of idiopathic thromboembolism during anticoagulant therapy.
abstract: Patients with acute pulmonary embolism and venous thromboembolism are usually treated with anticoagulant therapy for at least 3 months as the optimum duration. A patient with recurrent idiopathic venous thromboembolism at the eighth month during anticoagulation (warfarin to target international normalized ratio of 2.0-3.0) is described. The case suggests that patients with idiopathic venous thromboembolism have a high risk of recurrence, even if a strict anticoagulant regimen is followed.
authors.affiliation: Second Department of Internal Medicine, Kagawa Medical University, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Tanimoto
authors.forename: K
authors.initials: K
authors.lastname: Mizushige
authors.forename: K
authors.initials: K
authors.lastname: Yukiiri
authors.forename: T
authors.initials: T
authors.lastname: Ueda
authors.forename: W
authors.initials: W
authors.lastname: Yoshihiro
authors.forename: K
authors.initials: K
authors.lastname: Ohmori
authors.forename: M
authors.initials: M
authors.lastname: Kohno
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy*; D012008:Recurrence; D013923:Thromboembolism / Q000188:drug therapy / Q000209:etiology*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D014859:Warfarin